Detalhe da pesquisa
1.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 16, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166764
2.
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 136, 2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765293
3.
Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists.
Nutr Cancer
; 74(7): 2392-2399, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856863
4.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703239
5.
Coronaphobia: A barrier to ongoing cancer treatment?
Psychooncology
; 31(7): 1178-1185, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194885
6.
Detachment and embolization of totally implantable central venous access devices: diagnosis and management.
Acta Chir Belg
; 122(4): 240-247, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33645456
7.
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
BMC Cancer
; 24(1): 114, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262962
8.
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer
; 23(1): 192, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849943
9.
Safety, Feasibility, and Efficacy of Capecitabine Maintenance in Patients With Advanced Gastric Cancer: A Retrospective Study.
Am J Ther
; 23(6): e1493-e1497, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25397587
10.
Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience.
Contemp Oncol (Pozn)
; 20(2): 141-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27358593
11.
Revisiting post-gastrectomy anemia with a brief survey among a group of Turkish medical oncologists.
J BUON
; 20(3): 808-11, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214634
12.
Progesterone receptor status in determining the prognosis of estrogen receptor positive/ HER2 negative breast carcinoma patients.
J BUON
; 20(1): 28-34, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778292
13.
Treatment decision plans matter in elderly patients with gastrointestinal cancer: suboptimal or optimal?
J BUON
; 19(2): 365-71, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965393
14.
Sequential therapy and prognostic factors in metastatic renal cell carcinoma: single centre experience.
J BUON
; 19(4): 1062-9, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536617
15.
Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients.
Contemp Oncol (Pozn)
; 18(3): 204-10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25520582
16.
Is virtual nutritional counseling efficacious for cancer patients during the COVID-19 pandemic?
J Telemed Telecare
; 30(1): 79-89, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36912038
17.
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.
Expert Opin Pharmacother
; 25(4): 477-484, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38568074
18.
Assessment of general characteristics of patients with primary metastatic breast carcinoma: single center experience.
Contemp Oncol (Pozn)
; 17(5): 450-5, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24596535
19.
Validation of bioelectrical impedance analysis in the evaluation of body composition in patients with breast cancer.
Nutr Clin Pract
; 38(4): 817-829, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579726
20.
XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer.
Hepatogastroenterology
; 59(120): 2635-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22534542